Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 603

1.

A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Hiligsmann M, Cooper C, Guillemin F, Hochberg MC, Tugwell P, Arden N, Berenbaum F, Boers M, Boonen A, Branco JC, Maria-Luisa B, Bruyère O, Gasparik A, Kanis JA, Kvien TK, Martel-Pelletier J, Pelletier JP, Pinedo-Villanueva R, Pinto D, Reiter-Niesert S, Rizzoli R, Rovati LC, Severens JL, Silverman S, Reginster JY.

Semin Arthritis Rheum. 2014 Jun 27. pii: S0049-0172(14)00161-9. doi: 10.1016/j.semarthrit.2014.06.005. [Epub ahead of print] Review.

PMID:
25086470
[PubMed - as supplied by publisher]
Free Article
2.

When is a health-care quality indicator ready to use?

Tugwell P, Knottnerus JA.

J Clin Epidemiol. 2014 Sep;67(9):961-2. doi: 10.1016/j.jclinepi.2014.07.001. Epub 2014 Jul 22. No abstract available.

PMID:
25063557
[PubMed - in process]
3.

Mapping of the OMERACT core set for ANCA-associated vasculitis to the international classification of function, disability and health.

Milman N, Boonen A, Merkel PA, Tugwell P.

Arthritis Care Res (Hoboken). 2014 Jul 21. doi: 10.1002/acr.22414. [Epub ahead of print]

PMID:
25048363
[PubMed - as supplied by publisher]
4.

Multiple testing in big data.

Knottnerus JA, Tugwell P.

J Clin Epidemiol. 2014 Aug;67(8):843-4. doi: 10.1016/j.jclinepi.2014.05.009. No abstract available.

PMID:
24947125
[PubMed - indexed for MEDLINE]
5.

Whither core outcome sets?

Tugwell P, Knottnerus JA.

J Clin Epidemiol. 2014 Jul;67(7):731-3. doi: 10.1016/j.jclinepi.2014.05.001. No abstract available.

PMID:
24928330
[PubMed - in process]
6.

Methotrexate for treating rheumatoid arthritis.

Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME.

Cochrane Database Syst Rev. 2014 Jun 10;6:CD000957. doi: 10.1002/14651858.CD000957.pub2.

PMID:
24916606
[PubMed - in process]
7.

Monitoring the ability to deliver care in low- and middle-income countries: a systematic review of health facility assessment tools.

Nickerson JW, Adams O, Attaran A, Hatcher-Roberts J, Tugwell P.

Health Policy Plan. 2014 Jun 3. pii: czu043. [Epub ahead of print] Review.

PMID:
24895350
[PubMed - as supplied by publisher]
8.

Updating the OMERACT filter at OMERACT 11.

Kirwan JR, Boers M, Tugwell P.

J Rheumatol. 2014 May;41(5):975-7. doi: 10.3899/jrheum.131306.

PMID:
24788466
[PubMed - in process]
9.

Improving the clinical significance of medical research.

Knottnerus JA, Tugwell P.

J Clin Epidemiol. 2014 Jun;67(6):607-8. doi: 10.1016/j.jclinepi.2014.03.009. No abstract available.

PMID:
24767517
[PubMed - indexed for MEDLINE]
Free Article
10.

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

Shea B, Swinden MV, Ghogomu ET, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P.

J Rheumatol. 2014 Jun;41(6):1049-60. doi: 10.3899/jrheum.130738. Epub 2014 Apr 15.

PMID:
24737913
[PubMed - in process]
11.

Does response shift bias invalidate asking patients if they are better or worse?

Tugwell P, Knottnerus JA.

J Clin Epidemiol. 2014 May;67(5):485-6. doi: 10.1016/j.jclinepi.2014.02.007. No abstract available.

PMID:
24698294
[PubMed - indexed for MEDLINE]
Free Article
12.

Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity.

Tugwell P, Boers M, D'Agostino MA, Beaton D, Boonen A, Bingham CO 3rd, Choy E, Conaghan PG, Dougados M, Duarte C, Furst DE, Guillemin F, Gossec L, Heiberg T, van der Heijde DM, Hewlett S, Kirwan JR, Kvien TK, Landewé RB, Mease PJ, Østergaard M, Simon L, Singh JA, Strand V, Wells G.

J Rheumatol. 2014 May;41(5):1000-4. doi: 10.3899/jrheum.131310. Epub 2014 Apr 1.

PMID:
24692531
[PubMed - in process]
13.

Updating the OMERACT filter: discrimination and feasibility.

Wells G, Beaton DE, Tugwell P, Boers M, Kirwan JR, Bingham CO 3rd, Boonen A, Brooks P, Conaghan PG, D'Agostino MA, Dougados M, Furst DE, Gossec L, Guillemin F, Helliwell P, Hewlett S, Kvien TK, Landewé RB, March L, Mease PJ, Ostergaard M, Simon L, Singh JA, Strand V, van der Heijde DM.

J Rheumatol. 2014 May;41(5):1005-10. doi: 10.3899/jrheum.131311. Epub 2014 Apr 1.

PMID:
24692522
[PubMed - in process]
14.

Updating the OMERACT filter: core areas as a basis for defining core outcome sets.

Kirwan JR, Boers M, Hewlett S, Beaton D, Bingham CO 3rd, Choy E, Conaghan PG, D'Agostino MA, Dougados M, Furst DE, Guillemin F, Gossec L, van der Heijde DM, Kloppenburg M, Kvien TK, Landewé RB, Mackie SL, Matteson EL, Mease PJ, Merkel PA, Ostergaard M, Saketkoo LA, Simon L, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2014 May;41(5):994-9. doi: 10.3899/jrheum.131309. Epub 2014 Mar 15.

PMID:
24634204
[PubMed - in process]
15.

A proof-of-concept study of ANSWER, a web-based methotrexate decision aid for patients with rheumatoid arthritis.

Li LC, Adam PM, Backman CL, Lineker S, Jones CA, Lacaille D, Townsend AF, Yacyshyn E, Yousefi C, Tugwell P, Leese J, Stacey D.

Arthritis Care Res (Hoboken). 2014 Mar 12. doi: 10.1002/acr.22319. [Epub ahead of print]

PMID:
24623617
[PubMed - as supplied by publisher]
16.

Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.

Boers M, Idzerda L, Kirwan JR, Beaton D, Escorpizo R, Boonen A, Magasi S, Sinha I, Stucki G, Tugwell P.

J Rheumatol. 2014 May;41(5):978-85. doi: 10.3899/jrheum.131307. Epub 2014 Mar 1.

PMID:
24584922
[PubMed - in process]
17.

Updating the OMERACT filter: implications for patient-reported outcomes.

Kirwan JR, Bartlett SJ, Beaton DE, Boers M, Bosworth A, Brooks PM, Choy E, de Wit M, Guillemin F, Hewlett S, Kvien TK, Landewé RB, Leong AL, Lyddiatt A, March L, May J, Montie PL, Nikaï E, Richards P, Voshaar MM, Smeets W, Strand V, Tugwell P, Gossec L.

J Rheumatol. 2014 May;41(5):1011-5. doi: 10.3899/jrheum.131312. Epub 2014 Mar 1.

PMID:
24584919
[PubMed - in process]
18.

Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.

Idzerda L, Rader T, Tugwell P, Boers M.

J Rheumatol. 2014 May;41(5):986-93. doi: 10.3899/jrheum.131308. Epub 2014 Mar 1.

PMID:
24584917
[PubMed - in process]
19.

Updating the OMERACT filter: implications for imaging and soluble biomarkers.

D'Agostino MA, Boers M, Kirwan J, van der Heijde D, Østergaard M, Schett G, Landewé RB, Maksymowych WP, Naredo E, Dougados M, Iagnocco A, Bingham CO 3rd, Brooks PM, Beaton DE, Gandjbakhch F, Gossec L, Guillemin F, Hewlett SE, Kloppenburg M, March L, Mease PJ, Moller I, Simon LS, Singh JA, Strand V, Wakefield RJ, Wells GA, Tugwell P, Conaghan PG.

J Rheumatol. 2014 May;41(5):1016-24. doi: 10.3899/jrheum.131313. Epub 2014 Mar 1.

PMID:
24584916
[PubMed - in process]
20.

How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.

Boers M, Kirwan JR, Gossec L, Conaghan PG, D'Agostino MA, Bingham CO 3rd, Brooks PM, Landewé R, March L, Simon L, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2014 May;41(5):1025-30. doi: 10.3899/jrheum.131314. Epub 2014 Mar 1.

PMID:
24584913
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk